You are here

  • Home
  • Archive
  • Volume 2, Issue 5
  • Review: Discontinuation rates are the same for serotonin-specific reuptake inhibitors and newer tricyclie and heteracyclic antidepressants

Article info

Article menu
Download PDFPDF
Therapeutics
Review: Discontinuation rates are the same for serotonin-specific reuptake inhibitors and newer tricyclie and heteracyclic antidepressants

Citation

Review: Discontinuation rates are the same for serotonin-specific reuptake inhibitors and newer tricyclie and heteracyclic antidepressants
BMJ Evidence-Based Medicine 1997;2:149.
Online issue publication 
March 02, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions